TY - JOUR
T1 - Radiation protection in proton therapy
T2 - Insights from a multi-institutional survey and experimental measurements within the SINFONIA project
AU - De Saint-Hubert, Marijke
AU - Romero-Expósito, Maite
AU - Liszka, Malgorzata
AU - Van Hoey, Olivier
AU - Pinasti, Sita
AU - Eliasson, Linda
AU - Lillhok, Jan
AU - Domingo, Carles
AU - Struelens, Lara
AU - Dasu, Alexandru
N1 - Publisher Copyright:
© 2025 Associazione Italiana di Fisica Medica e Sanitaria
PY - 2025/9
Y1 - 2025/9
N2 - Purpose: This study, part of the EU-funded SINFONIA project, addresses radiation protection concerns in daily PT practice to study potentially under- or overprotection of staff depending on their working environment and tasks. Methods: A multi-institutional survey was carried out, complemented by specific neutron dose measurements at a PT centre. Besides mono-energetic irradiations, clinical treatments for brain, thorax (Hodgkin's lymphoma — HL) and pelvis (prostate), were investigated with and without range shifter (RS). The Thermo Fisher Scientific WENDI II and Berthold LB6411 ambient neutron monitors and two DIAMON neutron spectrometers were used for H*(10). Furthermore, BTI BD-PND bubble detectors, LANDAUER Neutrak dosimeters and Intercast CR-39 + plastic converters were also tested for Hp(10). Results: Initial survey results suggest no considerable risk for staff, with doses registering below 1 mSv/year. Further, site-specific measurements conducted at the Skandion facility, unveil annual staff doses ranging from 5–10 μSv in the staff control room. Accidental exposure scenarios on the other hand could reach up to 0.26 μSv/Gy in the gantry pit. Notably, H*(10) detectors demonstrated good performance, while Hp(10) dosimeters solely captured doses within the treatment room, yet remaining in agreement with reference values. Conclusion: Findings suggest a minimal neutron exposure risk for staff members within contemporary PT facilities.
AB - Purpose: This study, part of the EU-funded SINFONIA project, addresses radiation protection concerns in daily PT practice to study potentially under- or overprotection of staff depending on their working environment and tasks. Methods: A multi-institutional survey was carried out, complemented by specific neutron dose measurements at a PT centre. Besides mono-energetic irradiations, clinical treatments for brain, thorax (Hodgkin's lymphoma — HL) and pelvis (prostate), were investigated with and without range shifter (RS). The Thermo Fisher Scientific WENDI II and Berthold LB6411 ambient neutron monitors and two DIAMON neutron spectrometers were used for H*(10). Furthermore, BTI BD-PND bubble detectors, LANDAUER Neutrak dosimeters and Intercast CR-39 + plastic converters were also tested for Hp(10). Results: Initial survey results suggest no considerable risk for staff, with doses registering below 1 mSv/year. Further, site-specific measurements conducted at the Skandion facility, unveil annual staff doses ranging from 5–10 μSv in the staff control room. Accidental exposure scenarios on the other hand could reach up to 0.26 μSv/Gy in the gantry pit. Notably, H*(10) detectors demonstrated good performance, while Hp(10) dosimeters solely captured doses within the treatment room, yet remaining in agreement with reference values. Conclusion: Findings suggest a minimal neutron exposure risk for staff members within contemporary PT facilities.
KW - Occupational exposure
KW - Proton therapy
KW - Radiation protection
UR - https://portalrecerca.uab.cat/en/publications/480531c3-39b2-40c8-9e44-2208fcff6d6d
UR - https://www.mendeley.com/catalogue/1a06ff6b-e9c1-3051-a33e-847b244dfdc2/
U2 - 10.1016/j.ejmp.2025.105049
DO - 10.1016/j.ejmp.2025.105049
M3 - Article
C2 - 40811923
AN - SCOPUS:105013227344
SN - 1120-1797
VL - 137
JO - Physica Medica
JF - Physica Medica
M1 - 105049
ER -